GOCO earnings analysis
What we found in GOCO's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
GoHealth, Inc. reported a significant decline in Q1 2026 financial performance, with revenues of $11.914 million, down 94.6% year-over-year, and an operating loss of $34.794 million. The company continues to face challenges in the Medicare market following a strategic pullback in Medicare Advantage activities, resulting in a substantial negative sentiment around its cash flow and profitability.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Sharp Revenue Decline
- Revenue fell to $11.914 million from $220.972 million a year ago, representing a 94.6% decline.
- Increasing Operating Losses
- Operating loss escalated to $34.794 million for the quarter compared to an income of $6.669 million in the same quarter last year.
- Costs Pressure
- Total operating expenses decreased to $46.708 million from $214.303 million, but still contributed to heavy losses.
- Decrease in Consumer Engagement
- Submissions dropped dramatically to 18,615 from 303,026 year-over-year, a 93.9% decline.
- Positive Operating Cash Flow
- Operating cash flow turned positive, at $6.986 million, compared to a negative $12.405 million in Q1 2025.
- Elevated Interest Expenses
- Interest expense grew significantly to $30.786 million from $15.954 million, largely due to increased borrowings.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Severe Liquidity Risk
- Management expressed substantial doubt about the company's ability to continue as a going concern due to liquidity covenant risks.
- Revenue Concentration Risk
- The company's focus shift toward GoHealth Protect and away from traditional Medicare Advantage has raised concerns about revenue stability.
- High Debt Levels
- Total debt remained high at $701.8 million, with an effective interest rate of 14.65%, creating sustainability risks.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-37.17
What they said about what is next.
Management anticipates ongoing challenges amid strategic adjustments and liquidity concerns.
The filing reads worse than the one before it.
What came before.
- 10-K · March 31, 2026
- GoHealth presents a consumer-focused, AI-enabled Medicare marketplace anchored on its Encompass operating model and proprietary LeadScore/PlanFit technologies, targeting ~68.0 million Medicare-eligible Americans.…
- 10-Q · November 14, 2025
- GoHealth reported a sharp revenue collapse to $34,186,000 in Q3 2025 and a heavy GAAP loss driven by a large impairment; net loss for the quarter was $(313,918,000) and net loss attributable to GoHealth, Inc. was…
- 10-Q · November 7, 2024
- GoHealth reported net revenues of $118,292 for the quarter ended September 30, 2024, down from $132,037 in the prior-year quarter (a $13,745 decline). Operating loss widened to $(42,672) (operating margin -36.1%) while…
- 10-Q · May 9, 2023
- GoHealth reported Q1 2023 revenue of $183.158M, down from $270.593M in Q1 2022 (‑$87.435M, ‑32.3%), while operating loss narrowed to $(5.749)M from $(25.308)M a year ago and net loss per Class A share improved to…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing GOCO makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever